CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 234 participants.
Also called NCT01877746
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 234 participants
- Registry
-
NCT01877746
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Unknown status
Technical summary
Registry record NCT01877746. Randomized; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
- Condition
- Inflammatory Cardiomyopathy
- Intervention (Drug)
- Combination of prednisone and azathioprine
- Intervention (Drug)
- Combination of prednisone and azathioprine
- Intervention (Other)
- No intervention
- Lead sponsor
- St. Anne's University Hospital Brno, Czech Republic
Record details
- Record id
cardio:ct-nct01877746- Content hash
26c16c77ac6ae0805c26e938ab99c34230f74c0c6474959b03c1078fa1b52dd5